Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)

Benzer Materyaller

• Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
  Yazar:: Hirani, SP, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study
  Yazar:: Mulligan, K, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
  Yazar:: Mulligan, Kathleen, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
  Yazar:: Moncrieffe, H, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
  Yazar:: Patrick F, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-09-01)